Emjard M 12.5mg/500mg (14 Tablet / Pack)
Prescription dual-action combination tablet used to treat type 2 diabetes mellitus.
Emjard M 12.5mg/500mg Tablets are an oral prescription combination hypoglycemic medication designed for type 2 diabetes management. The active ingredients work synergistically to enhance peripheral insulin sensitivity while safely increasing glucose excretion through the kidneys. It is prescribed alongside strict dietary modifications and structured exercise routines to lower elevated HbA1c levels.
Purpose
Used to enhance insulin sensitivity and promote urinary excretion of glucose.
Ingredients
Empagliflozin 12.5mg, Metformin HCl 500mg
Warnings
Discontinue immediately if patient develops deep, rapid breathing or vomiting. Avoid excessive or chronic alcohol intake while utilizing this medication. Not suitable for treating diabetic ketoacidosis or type 1 diabetes. Monitor renal function parameters regularly throughout the treatment timeline.
Side Effects
Diarrhea or abdominal gas Nausea or loss of appetite Increased frequency of urination Localized genital yeast infections
Storage Instructions
Store below 30°C in a dry environment out of children's reach.
| Status | Active |
Related Products
Vesun Sunblock Cream Spf60 (60g)
Venlay Skin Brightening Cream (100g)
Venlay Brightening Face Wash (100ml)
Sylic A Serum (20ml)
Sylic A Face Wash (100ml)
Rucid syrup (120ml)
Rivia Anti Dandruff Shampoo (120ml)
